Thyroid Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

Thyroid Cancer Diagnostic Trends and Forecast

The future of the global thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets. The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030 with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are the increasing incidence of thyroid cancer, growing focus on real time diagnosis and treatment, and rising awareness towards thyroid cancer.

A more than 150-page report is developed to help in your business decisions.

Thyroid Cancer Diagnostic by Segment

The study includes a forecast for the global thyroid cancer diagnostic by product type, test type, end use, and region.

Thyroid Cancer Diagnostic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables & Accessories

Thyroid Cancer Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Imaging Test
• Biopsy
• Blood Test
• Others

Thyroid Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospital
• Associated Labs
• Independent Diagnostic Laboratories
• Diagnostic Imaging Centers
• Cancer Research Institutes
• Others

Thyroid Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Thyroid Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid cancer diagnostic companies profiled in this report include-

• Abbott
• Hoffmann-La Roche
• Thermo Fisher Scientific
• Siemens Healthcare
• Bio-Rad Laboratories
• General Electric
• Koninklijke Philips
• Toshiba Corporation
• Agilent Technologies
• Illumina

Thyroid Cancer Diagnostic Market Insights

Lucintel forecasts that imaging test will remain the largest segment due to the increasing demand of high resolution and real time image testing.

Within this market, hospitals will remain the largest segmnt over the forecast period due to growing inflow of cancer diagnosis patient in hospitals, increasing consumer awareness, and growing investments in healthcare infrastructure across the globe.

North America will remain the largest region due to increasing prevalence of thyroid cancer, rising healthcare expenditure, and favourable government initiative in the US for awareness, diagnostic and treatment.

Features of the Global Thyroid Cancer Diagnostic Market

Market Size Estimates: Thyroid cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Thyroid cancer diagnostic market size by product type, test type, end use, and region in terms of value ($B).

Regional Analysis: Thyroid cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, test types, end uses, and regions for the thyroid cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the thyroid cancer diagnostic market size?

Answer: The global thyroid cancer diagnostic market is expected to reach an estimated $7.6 billion by 2030.

Q.2 What is the growth forecast for thyroid cancer diagnostic market?

Answer: The global thyroid cancer diagnostic market is expected to grow with a CAGR of 5.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the thyroid cancer diagnostic market?

Answer: The major drivers for this market are the increasing incidence of thyroid cancer, growing focus on real time diagnosis and treatment, and rising awareness towards thyroid cancer.

Q4. What are the major segments for thyroid cancer diagnostic market?

Answer: The future of the thyroid cancer diagnostic market looks promising with opportunities in the hospital, associated lab, independent diagnostic laboratory, diagnostic imaging center, and cancer research institute markets.

Q5. Who are the key thyroid cancer diagnostic market companies?

Answer: Some of the key thyroid cancer diagnostic companies are as follows:

• Abbott
• Hoffmann-La Roche
• Thermo Fisher Scientific
• Siemens Healthcare
• Bio-Rad Laboratories
• General Electric
• Koninklijke Philips
• Toshiba Corporation
• Agilent Technologies
• Illumina

Q6. Which thyroid cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that imaging test will remain the largest segment due to the increasing demand of high resolution and real time image testing.

Q7. In thyroid cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing prevalence of thyroid cancer, rising healthcare expenditure, and favourable government initiative in the US for awareness, diagnostic and treatment.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the thyroid cancer diagnostic market by product type (instruments and consumables & accessories), test type (imaging test, biopsy, blood test, and others), end use (hospital, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?